Moderna Announces an Organizational Restructuring

Cambridge, MA — July 31, 2025 — Moderna today announced an organizational restructuring that will reduce its global workforce by approximately 10 percent. This action is part of the Company’s previously stated plan to decrease estimated GAAP operating expenses by $1.4 to $1.7 billion by 2027 and better align its cost structure and capabilities with current business conditions while also sustaining investment in its mRNA pipeline. Affected employees will receive severance, equity vesting and comprehensive transition support. Moderna anticipates a total headcount of under 5,000 employees by year-end.